The third edition of Vinexpo Shanghai is set to take place from 20 to 22 October 2021 at the Shanghai World Expo Exhibition & Convention Center (SWEECC).
 
Due to the pandemic, Vinexpo Shanghai was held in digital format in 2020. The 2021 edition will mark the return of Vinexposium’s physical events in Shanghai. According to the organiser, “extensive on-the-ground work carried out by its local team will enable Vinexpo Shanghai 2021 to showcase a range of products geared to market recovery”. Both local and international brands will be on show to present to trade visitors.
 
This will be Vinexposium group’s first physical event since the beginning of the pandemic in China, where all exhibitions have already resumed business. Since the launch of Vinexpo Shanghai in 2019, which attracted great interest from the industry, Vinexposium has strengthened its local footing by opening an office based in Shanghai.
 
The entire portfolio of events of the organiser is promoted and mainland China’s wine and spirits market is canvassed. This has allowed Vinexpo Shanghai to develop the ability to introduce promotion thrusts tailored specifically to China and welcome regional producers alongside international producers. Highly targeted promotion work supervised by the group’s local teams will bolster attendance of the visitors by key buyers and help demonstrate the event’s powerful upswing and development.
 
China is a country where consumption of imported wines and spirits is no longer restricted to large cities. Vinexpo Shanghai will continue to provide a global business platform where the decision has been made to ramp up participation by spirits with a range of local and international products.
 
Rodolphe Lameyse, CEO of the Vinexposium group, commented: “We are delighted that the return of Vinexpo Shanghai in a physical format will enable us to once again bring together wine and spirits players at an event that will focus on tastings and the engagement with others that we have all sorely missed. As the crisis draws to an end due to the vaccination programme, it marks the resumption of alluring growth dynamics in China, where the market offers strong prospects for value creation over the next five years.”